Stockscreener 앱 받기
59.13
0.15%
-0.09
Veracyte Inc 주식(VCYT)의 최신 뉴스
This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Sahm
A Look at Veracyte Inc (VCYT) After 5.1% Gain -- GF Value $38.30 vs Price $59.51 - GuruFocus
Piper Sandler Initiates Veracyte(VCYT.US) With Buy Rating, Announces Target Price $66 - Moomoo
Piper Sandler initiates Veracyte stock with overweight rating By Investing.com - Investing.com Nigeria
Piper Sandler Initiates Veracyte at Overweight With $66 Price Target - marketscreener.com
VCYT Initiated Coverage by Piper Sandler -- Rating Overweight - GuruFocus
CCORF Maintains Veracyte(VCYT.US) With Hold Rating, Raises Target Price to $60 - Moomoo
VCYT Maintained by Canaccord Genuity -- Price Target Raised to $60 - GuruFocus
Here's how much you'd have if you invested $1000 in Veracyte a decade ago - MSN
Morgan Stanley Maintains Veracyte(VCYT.US) With Sell Rating, Raises Target Price to $47 - Moomoo
Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026 - BioSpace
A Look at Veracyte Inc (VCYT) After 5.5% Gain -- GF Value $38.24 vs Price $59.30 - GuruFocus
VCYT Maintained by Morgan Stanley -- Price Target Raised to $47. - GuruFocus
Press Release: Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026 - Moomoo
St. Pete woman seeks $10M in discrimination lawsuit against employer - Business Observer
Veracyte, Inc. Stock 12‑Month Price Target Raised to $55.8, Implies 1% Downside - TradingView
Jefferies Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $70 - Moomoo
Does Veracyte’s (VCYT) Russell Value Index Debut Redefine Its Small-Cap Defensive Narrative? - simplywall.st
Veracyte Inc updates investors on breast cancer test coverage. Nasdaq-listed diagnostics group build - ad-hoc-news.de
All You Need to Know About Veracyte (VCYT) Rating Upgrade to Strong Buy - Yahoo Finance
Is Veracyte (VCYT) Fully Valued As Insider Selling And Index Additions Draw Attention? - simplywall.st
Landmark OPTIMA Trial Delivers Practice-Changing Evidence that Veracyte’s Prosigna Test Identifies Patients with High-Risk Breast Cancer Who Can Safely Avoid Chemotherapy - AOL.com
Veracyte Inc (VCYT) Stock Down 3.2% but Still Overvalued -- GF S - GuruFocus
Veracyte (VCYT) Edges Higher, Approaches Key Resistance Amid Steady TradingALMA Signal - dars.gov.et
Veracyte Inc (NASDAQ:VCYT) Fits the Affordable Growth Profile - ChartMill
A Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transaction. - Yahoo Finance
Veracyte Inc (VCYT) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Veracyte Stock Surges 117% in a Year: What's Driving the Rally? - TradingView
Veracyte Inc (VCYT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
VCYT Maintained by Guggenheim -- Price Target Raised to $65 - GuruFocus
Veracyte Price Target Raised to $65.00/Share From $45.00 by Guggenheim - Moomoo
Veracyte, Inc.(NasdaqGM: VCYT) added to Russell 2000 Value Benchmark - marketscreener.com
Veracyte (VCYT) Enters Multiple Russell Indexes Is Its Small-Cap Profile Quietly Changing? - simplywall.st
Price to book forward of Veracyte, Inc. – NASDAQ:VCYT - TradingView
Veracyte, Inc.(NasdaqGM: VCYT) added to Russell 2000 Value-Defensive Index - marketscreener.com
Veracyte, Inc.(NasdaqGM: VCYT) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Veracyte, Inc.(NasdaqGM: VCYT) added to Russell 3000E Value Benchmark - marketscreener.com
Price to sales forward of Veracyte, Inc. – NASDAQ:VCYT - TradingView
Enterprise value to EBIT forward of Veracyte, Inc. – NASDAQ:VCYT - TradingView
Veracyte, Inc.(NasdaqGM: VCYT) added to Russell 3000 Value Benchmark - marketscreener.com
Price to earnings forward of Veracyte, Inc. – NASDAQ:VCYT - TradingView
Price to earnings forward of Veracyte, Inc. – FWB:12V - TradingView
Price to sales forward of Veracyte, Inc. – FWB:12V - TradingView
Enterprise value to revenue forward of Veracyte, Inc. – FWB:12V - TradingView
Price to book forward of Veracyte, Inc. – FWB:12V - TradingView
Enterprise value to EBITDA forward of Veracyte, Inc. – NASDAQ:VCYT - TradingView
What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally - Yahoo Finance
Veracyte, Inc. Actuals & Estimates (TRADEGATE:12V) - TradingView
Veracyte, Inc. Actuals & Estimates (MUN:12V) - TradingView
Veracyte, Inc. Actuals & Estimates (DUS:12V) - TradingView
Q1 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q4 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q2 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q3 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Veracyte, Inc. Actuals & Estimates (NASDAQ:VCYT) - TradingView
Veracyte Inc (VCYT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
VCYT Forecast — Price Target — Prediction for 2027 - TradingView
12V Forecast — Price Target — Prediction for 2027 - TradingView
Veracyte Inc (VCYT) Shares Surge 3.1% -- What GF Score of 75 Tel - GuruFocus
Veracyte Jumps 7.2% Amid Sector-Wide Rally - AlphaStreet
Veracyte stock hits 52-week high at 55.32 USD By Investing.com - Investing.com Nigeria
Veracyte stock hits 52-week high at 55.32 USD - Investing.com
0.61%
1.88%
자본화:
|
볼륨(24시간):